本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 上海雅仕投资发展股份有限公司（以下简称"公司"）于近日收到国联民生 证券承销保荐有限公司（以下简称"国联民生"）出具的《关于更换上海雅仕投 资发展股份有限公司持续督导保荐代表人的函》。 国联民生作为公司 2024 年向特定对象发行股票项目的保荐机构，原指定金 城先生和周依黎女士为公司前述项目的持续督导保荐代表人，持续督导职责期限 至 2026 年 12 月 31 日止。现周依黎女士因工作变动不再担任公司的持续督导保 荐代表人，为保证持续督导工作有序进行，国联民生委派李大山先生接替周依黎 女士担任持续督导保荐代表人，继续履行持续督导责任。 本次保荐代表人变更后，公司向特定对象发行股票项目的持续督导保荐代表 人为金城先生和李大山先生。 公司董事会对原保荐代表人周依黎女士在公司向特定对象发行股票项目及 持续督导期间所做的工作表示衷心感谢！ 证券代码：603329 证券简称：上海雅仕 公告编号：2025-079 上海雅仕投资发展股份有限公司 关于变更持续督导保荐代表人的公告 2025 年 ...

Group 1 - The acquisition enthusiasm of local state-owned assets for controlling listed companies has surged, becoming a focal point in the capital market [1] - Hubei state-owned assets have accelerated their purchasing pace in the A-share market, with the number of listed companies under their actual control reaching 15 [1] - Hubei Wenlv acquired a 29.99% stake in Junting Hotel for a total price of 1.499 billion yuan, changing the controlling shareholder to Hubei Wenlv and the actual controller to Hubei Provincial State-owned Assets Supervision and Administration Commission [1][2] Group 2 - Hubei Wenlv's main business includes cultural tourism, commercial trade, and sports health, with assets exceeding 100 billion yuan [2] - After the acquisition, Hubei Wenlv plans to inject quality lodging assets into Junting Hotel and support its financing activities, aiming to make it a benchmark in the hotel industry and cultural tourism integration [2] - Hubei Jiaotou Group, a major state-owned enterprise, has also gained control of three listed companies, expanding its influence in various sectors including traditional and emerging industries [3] Group 3 - The acquisition wave of Hubei state-owned assets began in 2023, with several strategic acquisitions completed, making it one of the most active local state-owned entities in terms of acquiring listed companies [4] - Hubei state-owned assets are diversifying their investments into traditional sectors like chemicals and energy, as well as emerging sectors such as semiconductors and new energy [3][4] Group 4 - Hubei Provincial State-owned Assets Supervision and Administration Commission is promoting the concentration of quality state-owned resources into listed companies, with future expectations for semiconductor and digital economy assets to be injected into companies like Taiji Co. and Wanrun Technology [6] - The "Three Assets" reform in Hubei aims to optimize the use of idle assets, allowing companies to leverage their resources for financing and development [5][6]

Group 1 - The acquisition enthusiasm of local state-owned assets for listed companies is rising, with Hubei state-owned enterprises controlling 15 listed companies through various means [1] - Hubei Wenlv acquired 29.99% of Junting Hotel's shares for a total price of 1.499 billion yuan, changing the controlling shareholder to Hubei Wenlv and the actual controller to Hubei Provincial State-owned Assets Supervision and Administration Commission [1][2] - Hubei Wenlv plans to inject quality hospitality assets into Junting Hotel and support its financing activities, aiming to make it a benchmark in the hotel industry and cultural tourism integration [2] Group 2 - Hubei Jiaotou Group, a large state-owned enterprise, has now controlled three listed companies, including Chutian Expressway and Weichuang Optoelectronics, after acquiring Super Zhi Hang Ke [3] - Hubei state-owned assets are diversifying into traditional sectors like chemicals and energy, as well as emerging sectors such as semiconductors and new energy [3] - The acquisition wave of Hubei state-owned enterprises began in 2023, with multiple strategic acquisitions completed, making it one of the most active local state-owned entities in terms of acquiring listed companies [4] Group 3 - Hubei Provincial State-owned Assets Supervision and Administration Commission is utilizing specialized platforms to achieve precise industrial layout, with different groups focusing on technology, new energy, and cultural tourism [5] - The change in actual controllers to Hubei Provincial State-owned Assets Supervision and Administration Commission is expected to provide new development opportunities for these listed companies under the "Three Assets" reform [5] - Future asset injections into companies like Taiji Co. and Wanrun Technology are anticipated, particularly in the semiconductor and digital economy sectors [6]

上海雅仕投资发展股份有限公司 第四届董事会第十三次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 二、董事会会议审议情况 本次董事会会议审议并通过了以下议案： (一)审议通过《关于增加募投项目实施主体并使用部分募集资金向新增实施主体提供借款以实施募投项 目议案》 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603329 证券简称：上海雅仕 公告编号：2025-074 一、董事会会议召开情况 上海雅仕投资发展股份有限公司（以下简称"公司"）第四届董事会第十三次会议于2025年11月19日在公 司会议室以现场结合通讯表决方式召开，会议通知及相关资料已于2025年11月14日以电子邮件方式发 出。本次会议应出席会议的董事9名，实际出席会议的董事9名，其中现场参会董事4名，以通讯表决方 式参会董事5名，部分高级管理人员列席会议，本次会议由董事长刘忠义先生主持。会议参与表决人数 及召集、召开程序符合《公司法》和《公司章程》的有关规定，所作决议合法有效。 同意公司新增全资子公司湖北雅仕实业控股有限公司作为募投 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603329 证券简称：上海雅仕 公告编号：2025-076 上海雅仕投资发展股份有限公司 关于使用募集资金置换已支付发行 费用的自筹资金的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 上海雅仕投资发展股份有限公司（以下简称"公司""上海雅仕"）于2025年11月19日召开第四届董事会第 十三次会议，审议通过了《关于使用募集资金置换已支付发行费用的自筹资金的议案》，同意公司使用 募集资金置换已支付发行费用的自筹资金，置换金额为人民币752,830.19元（不含税），本次募集资金 置换时间距募集资金到账日未超过6个月，符合相关法律法规的规定。现将有关情况公告如下： 一、募集资金基本情况 经中国证券监督管理委员会《关于同意上海雅仕投资发展股份有限公司向特定对象发行股票注册的批 复》（证监许可〔2025〕1825号）同意，公司本次向特定对象发行人民币普通股（A股）43,668,122 股，发行价格6.87元/股，募集资金总额为299,999,998.14元，扣除不含 ...

（文章来源：证券日报） 证券日报网讯 11月19日晚间，上海雅仕发布公告称，公司于2025年11月19日召开第四届董事会第十三 次会议，审议通过了《关于使用募集资金置换已支付发行费用的自筹资金的议案》，同意公司使用募集 资金置换已支付发行费用的自筹资金，置换金额为人民币752，830.19元（不含税），本次募集资金置 换时间距募集资金到账日未超过6个月。 ...

证券日报网讯 11月19日晚间，上海雅仕发布公告称，公司于2025年11月19日召开第四届董事会第十三 次会议，审议通过了《关于增加募投项目实施主体并使用部分募集资金向新增实施主体提供借款以实施 募投项目的议案》，同意公司新增全资子公司湖北雅仕实业控股有限公司（简称"湖北雅仕"）作为募投 项目实施主体并开立募集资金专项账户，与公司共同实施"补充流动资金或偿还银行贷款项目"，并使用 部分募集资金向新增实施主体提供借款以实施募投项目。 （文章来源：证券日报） ...

Core Viewpoint - The company Shanghai Yashi Investment Development Co., Ltd. has approved a plan to utilize idle raised funds for cash management, aiming to enhance the efficiency of fund usage while ensuring normal operations and compliance with regulations [1][2]. Group 1: Cash Management Plan - The company will use up to 200 million yuan of idle raised funds for cash management, with an investment period of twelve months from the board's approval date [1]. - Investment products will focus on high safety and liquidity, including but not limited to seven-day notice deposits and fixed-term deposits [1]. - The funds will come from idle raised funds from a specific stock issuance in 2024, ensuring that all deposits are kept in established special accounts for raised funds [1]. Group 2: Risk Control and Compliance - The company will adhere to prudent investment principles, selecting quality investment targets and monitoring product allocation and project progress [1]. - The plan has received a no-objection opinion from the sponsor institution, confirming that it complies with relevant regulations and does not harm shareholder interests [2]. - The board has authorized the chairman and designated individuals to make investment decisions within the approved limits without needing to submit the proposal to the shareholders' meeting [2].

Group 1 - Kanglongda's shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 4.83 million shares [1] - The company specializes in the research, production, and sales of special and ordinary labor protection gloves [1] Group 2 - Haizheng Pharmaceutical's subsidiary plans to collaborate with East China Institute on a biological method for synthesizing heparin, with a project contract amount not exceeding 120 million yuan [2] - The company focuses on the research, production, and sales of chemical raw materials and formulations [3] Group 3 - Tianyin Holdings received approval from the China Securities Regulatory Commission for a stock issuance to specific investors [4] - The company is engaged in the sales of smart terminals, e-commerce, lottery, mobile resale, and mobile internet businesses [4] Group 4 - Shanghai Yashi plans to use up to 200 million yuan of temporarily idle raised funds for cash management in high-security, liquid deposit products [5] - The company specializes in supply chain logistics and execution trade [6] Group 5 - Parker New Materials intends to use 130 million yuan of idle raised funds to purchase structured deposits with expected annual yields between 0.59% and 2.9001% [7] - The company focuses on the research, production, and sales of various types of ring forgings, free forgings, and die forgings [7] Group 6 - Huayang New Materials appointed Jing Hongsheng as the new general manager [8] Group 7 - Liyuan Technology's shareholder plans to reduce holdings by up to 2.03% of the company's shares, totaling no more than 3.04 million shares [9] - The company specializes in the research, design, and integration of environmental water treatment systems and hydrogen fuel cell engine systems [9] Group 8 - Shengnuo Biopharmaceutical's subsidiary received approval for the listing application of Visepegenatide raw materials, a GLP-1 receptor agonist for treating type 2 diabetes and obesity [10][11] - The company focuses on the research, production, and sales of peptide raw materials and formulations [10] Group 9 - Puluo Pharmaceutical plans to repurchase shares worth between 180 million and 360 million yuan, with a maximum price of 23 yuan per share [12] - The company specializes in the research, production, and sales of raw material intermediates and innovative drugs [12] Group 10 - Dongfang Electric's subsidiary plans to establish a joint venture with Anhui Waneng Energy, with a registered capital of approximately 1.857 billion yuan [13] - The company is involved in the development, design, manufacturing, and sales of advanced power generation equipment [13] Group 11 - Hefei China announced that its stock will resume trading on November 20 after completing a review of abnormal trading fluctuations [14] - The company focuses on international trade and after-sales services related to in vitro diagnostic medical devices [14] Group 12 - Dafeng Industrial won a bid for the stage equipment project of the Shenzhen International Performing Arts Center, with a contract amount of 165 million yuan [15] - The company specializes in cultural sports equipment, digital art technology, and operation services [15] Group 13 - Baiyunshan's subsidiary received a drug registration certificate for An Gong Niu Huang Wan in Vietnam [16] - The company is engaged in the research, manufacturing, and sales of traditional Chinese and Western medicines [16] Group 14 - Neusoft Group received a notification to supply intelligent cockpit domain controllers for multiple models from a well-known domestic automobile manufacturer, with an estimated total amount of about 4.2 billion yuan [17] - The company focuses on providing industry solutions and software products [17] Group 15 - Huayu Pharmaceutical's product received overseas marketing approval [18] - The company specializes in the research, production, and sales of innovative and high-quality generic drugs in the oncology field [18] Group 16 - Yao Pi Glass received approval from the CSRC for its stock issuance to specific investors [19] - The company specializes in the production and sales of float glass and processed glass [19] Group 17 - Guangyu Yuan's vice president Wang Junbo resigned due to work adjustments [20] - The company focuses on the production and sales of traditional Chinese medicine products [20] Group 18 - Biyi Co. received approval from the CSRC for its stock issuance to specific investors [21] - The company specializes in the design, manufacturing, and sales of smart small household appliances [21] Group 19 - Sunshine Nuohe's application for acquiring 100% equity of Jiangsu Langyan Life Science Technology Co., Ltd. through share issuance and convertible bonds has been accepted by the Shanghai Stock Exchange [22] - The company provides comprehensive drug research and development services for domestic pharmaceutical enterprises and research institutions [22] Group 20 - Longxin General plans to increase capital in its wholly-owned subsidiary by no more than 1.65 billion yuan [23] - The company specializes in the research, production, and sales of motorcycles and engines [23] Group 21 - Jiekang Equipment received a corrective order from the Tianjin Securities Regulatory Bureau due to internal control deficiencies [24] - The company specializes in the research, production, and sales of nuclear biochemical safety equipment [24] Group 22 - Wantong Technology plans to raise no more than 920 million yuan through a private placement to supplement working capital [25] - The company focuses on information technology services for highways and ports [25] Group 23 - Dongshan Precision has submitted an application for H-share listing to the Hong Kong Stock Exchange [26] - The company specializes in the research, production, and sales of electronic circuit products and precision components [26] Group 24 - Yonghe Intelligent Control plans to publicly transfer 100% equity of its wholly-owned subsidiary Kunming Medical Oncology Hospital [27] - The company specializes in water and heating valve fittings, tumor precision radiation therapy, and photovoltaic battery businesses [27] Group 25 - Aok Shares signed a strategic cooperation framework agreement with Suzhou Qitian New Materials Co., Ltd. [28] - The company focuses on the research and production of high-end new materials derived from ethylene oxide and ethylene [28] Group 26 - Hongquan Technology's shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 299,440 shares [29] - The company specializes in the research, production, and sales of intelligent connected products and software platform development [29] Group 27 - Shilong Industrial's controlling shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 7.2 million shares [30] - The company specializes in the research, production, and sales of chemical products [30] Group 28 - Tangrenshen decided to terminate the investment in the "Dongchong Phase III Pig Breeding Base Construction Project," reallocating the remaining funds of 78.9587 million yuan to supplement working capital [31] - The company specializes in the research, production, and sales of feed, pigs, meat products, and animal health products [31] Group 29 - Gaode Infrared's actual controller plans to reduce holdings by up to 3% of the company's shares, totaling no more than 12.8 million shares [32] - The company specializes in infrared focal plane detector chips and infrared thermal imaging systems [32] Group 30 - Kangyuan Pharmaceutical's actual controller recently increased holdings by 20,000 shares [33] - The company specializes in the research, production, and sales of pharmaceuticals [33] Group 31 - Haida Group plans to repurchase shares worth between 1 billion and 1.6 billion yuan, with a maximum price of 62.00 yuan per share [34] - The company provides overall solutions for animal husbandry [34] Group 32 - Qizhong Technology's 850 million yuan convertible bonds have been approved for listing [35] - The company specializes in advanced packaging and testing of integrated circuits [35] Group 33 - Dingyang Technology launched the new SNA5000B series vector network analyzer [36] - The company specializes in the research, production, and sales of general electronic testing and measuring instruments [36] Group 34 - Airo Energy plans to distribute a cash dividend of 0.9375 yuan per share to all shareholders [37] - The company specializes in photovoltaic energy storage systems and products [37] Group 35 - Hechuan Technology's actual controller and some directors plan to reduce holdings by up to 6% of the company's shares [38] - The company specializes in the research, production, and sales of industrial automation products [38] Group 36 - China First Heavy Industries' chairman was arrested for suspected bribery [39] - The company specializes in heavy machinery manufacturing for various industries [39] Group 37 - Lianhuan Pharmaceutical plans to invest 15 million yuan in joint research with Nanjing University for anti-thrombotic small nucleic acid drugs [40] - The company specializes in the manufacturing and sales of chemical raw materials [40] Group 38 - Anxu Biotech's shareholder plans to reduce holdings by up to 0.94% of the company's shares, totaling no more than 120,000 shares [41] - The company specializes in the research, production, and sales of POCT reagents and instruments [41] Group 39 - Yaxiang Integration's shareholder reduced holdings by 130,000 shares [42] - The company specializes in providing cleanroom engineering and related services for high-tech electronic industries [42] Group 40 - Zhongwen Media plans to use up to 9.5 billion yuan of idle funds to purchase financial products [43] - The company specializes in traditional publishing and various new media businesses [43]

Group 1 - The core point of the article is that Shanghai Yashi (SH 603329) held its 13th meeting of the fourth board of directors on November 19, 2025, to discuss the proposal for changing registered capital and amending the company's articles of association [1] - For the first half of 2025, Shanghai Yashi's revenue composition was as follows: supply chain execution trade accounted for 73.44%, multimodal transport 18.1%, third-party logistics services 7.87%, and other businesses 0.59% [1] - As of the report date, Shanghai Yashi's market capitalization was 3 billion yuan [1]